Guobang Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Guobang Pharma has a total shareholder equity of CN¥7.6B and total debt of CN¥1.0B, which brings its debt-to-equity ratio to 13.7%. Its total assets and total liabilities are CN¥10.4B and CN¥2.8B respectively. Guobang Pharma's EBIT is CN¥630.7M making its interest coverage ratio -16. It has cash and short-term investments of CN¥2.4B.
Key information
13.7%
Debt to equity ratio
CN¥1.04b
Debt
Interest coverage ratio | -16x |
Cash | CN¥2.38b |
Equity | CN¥7.61b |
Total liabilities | CN¥2.79b |
Total assets | CN¥10.40b |
Financial Position Analysis
Short Term Liabilities: 605507's short term assets (CN¥5.4B) exceed its short term liabilities (CN¥2.2B).
Long Term Liabilities: 605507's short term assets (CN¥5.4B) exceed its long term liabilities (CN¥617.0M).
Debt to Equity History and Analysis
Debt Level: 605507 has more cash than its total debt.
Reducing Debt: 605507's debt to equity ratio has reduced from 28% to 13.7% over the past 5 years.
Debt Coverage: 605507's debt is well covered by operating cash flow (21.8%).
Interest Coverage: 605507 earns more interest than it pays, so coverage of interest payments is not a concern.